SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-079929
Filing Date
2020-07-02
Accepted
2020-07-01 19:56:20
Documents
16
Period of Report
2020-06-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2023622-3_8k.htm   iXBRL 8-K 30123
2 EXHIBIT 1.1 tm2023622d3_ex1-1.htm EX-1.1 191205
3 EXHIBIT 5.1 tm2023622d3_ex5-1.htm EX-5.1 6659
4 EXHIBIT 99.1 tm2023622d3_ex99-1.htm EX-99.1 5079
8 GRAPHIC tm2023622d3_ex5-1.jpg GRAPHIC 10052
  Complete submission text file 0001104659-20-079929.txt   469247

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xlrn-20200630.xsd EX-101.SCH 3207
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE xlrn-20200630_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xlrn-20200630_pre.xml EX-101.PRE 22724
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2023622-3_8k_htm.xml XML 3480
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 201006683
SIC: 2836 Biological Products, (No Diagnostic Substances)